2vh5: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2vh5.png|left|200px]] | [[Image:2vh5.png|left|200px]] | ||
| Line 10: | Line 9: | ||
{{STRUCTURE_2vh5| PDB=2vh5 | SCENE= }} | {{STRUCTURE_2vh5| PDB=2vh5 | SCENE= }} | ||
===CRYSTAL STRUCTURE OF HRAS(G12V)- ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX=== | ===CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX=== | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[2vh5]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VH5 OCA]. | |||
==Reference== | ==Reference== | ||
| Line 33: | Line 32: | ||
[[Category: Golgi apparatus]] | [[Category: Golgi apparatus]] | ||
[[Category: Gtp-binding]] | [[Category: Gtp-binding]] | ||
[[Category: Immune system]] | |||
[[Category: Immunoglobulin domain]] | [[Category: Immunoglobulin domain]] | ||
[[Category: Intrabody]] | [[Category: Intrabody]] | ||
| Line 39: | Line 39: | ||
[[Category: Methylation]] | [[Category: Methylation]] | ||
[[Category: Nucleotide- binding]] | [[Category: Nucleotide- binding]] | ||
[[Category: Nucleotide-binding | [[Category: Nucleotide-binding]] | ||
[[Category: Oncogene]] | [[Category: Oncogene]] | ||
[[Category: Palmitate]] | [[Category: Palmitate]] | ||
| Line 46: | Line 46: | ||
[[Category: Signal transduction]] | [[Category: Signal transduction]] | ||
[[Category: Signaling protein/immune system]] | [[Category: Signaling protein/immune system]] | ||
Revision as of 19:43, 14 March 2011
CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX
Template:ABSTRACT PUBMED 18187153
About this Structure
2vh5 is a 3 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Tanaka T, Rabbitts TH. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. J Mol Biol. 2008 Feb 22;376(3):749-57. Epub 2007 Dec 4. PMID:18187153 doi:10.1016/j.jmb.2007.11.085
- Tanaka T, Williams RL, Rabbitts TH. Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. EMBO J. 2007 Jul 11;26(13):3250-9. Epub 2007 Jun 14. PMID:17568777
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Pages with broken file links
- Homo sapiens
- Rabbitts, T H.
- Tanaka, T.
- Williams, R L.
- Antibody
- Cancer therapy
- Disease mutation
- Golgi apparatus
- Gtp-binding
- Immune system
- Immunoglobulin domain
- Intrabody
- Lipoprotein
- Membrane
- Methylation
- Nucleotide- binding
- Nucleotide-binding
- Oncogene
- Palmitate
- Prenylation
- Proto-oncogene
- Signal transduction
- Signaling protein/immune system
